Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Vivos Therapeutics (VVOS) Long-Term Debt Issuances (2020 - 2025)

Vivos Therapeutics' Long-Term Debt Issuances history spans 2 years, with the latest figure at $1.4 million for Q4 2025.

  • Quarterly results put Long-Term Debt Issuances at $1.4 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $1.0 million (changed N/A YoY), and the annual figure for FY2025 was $10.7 million, changed.
  • Long-Term Debt Issuances for Q4 2025 was $1.4 million at Vivos Therapeutics, up from -$417000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $1.4 million in Q4 2025 to a low of -$417000.0 in Q3 2025.